MEDOVEX CORP. (NASDAQ:MDVX) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On May 24, 2017, Medovex Corp. (the “Company”) filed a request for an appeal in the form of an oral hearing of the determination of the Listing Qualifications Department of the NASDAQ Stock Market that it faces delisting of its securities on the Nasdaq Stock Market as a result of its stockholders’ equity as reported in its Form 10-Q for the quarter ended March 31, 2017 being below the minimum stockholders’ equity of $2,500,000 required for continued listing on the NASDAQ Capital Market as set forth in NASDAQ listing rule 5550(b)(1) (the “Rule”).
NASDAQ granted the Company’s request for an oral hearing and has scheduled the hearing for June 15, 2017. As a result, the Company’s securities will not be suspended at the opening of business on May 26, 2017.
MEDOVEX CORP. (NASDAQ:MDVX) Recent Trading Information
MEDOVEX CORP. (NASDAQ:MDVX) closed its last trading session down -0.13 at 1.12 with 211,389 shares trading hands.
MEDOVEX CORP. (NASDAQ:MDVX) closed its last trading session down -0.13 at 1.12 with 211,389 shares trading hands.
